WaveMan
WaveMan · Company
KRMD · Koru Medical Systems, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

KRMD KORU Medical Systems (KRMD) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0000704440
Quote by TradingView
Cluster · 5 insidersC-suite buying · 5Form 144 · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
43
13F, latest reported quarter
Conversions, 180 days
4
Codes C/M, not in net · $0 priced

What the filings say about KRMD

Insiders, 180 days
+$1.6M net bought
5 buyers
Planned sales (Form 144), 90 days
$108.6K
1 notice

KORU Medical Systems insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, KORU Medical Systems, Inc. insiders bought a net $1.6M of stock across 21 Form 4 purchases and sales, with 5 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
KALBERMATTEN ADAM R
Chief Commercial Officer
BUY
2026-09-09 SECtraded 2026-09-08
32,000
$101.1K
-1.0%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Jun 11, 2026.
  • The trade is 8.1% of the 394,017 shares held after it.
  • No other insider bought within 30 days.
  • 43 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Commercial Officer KALBERMATTEN ADAM R bought about $101.1K of KRMD on Sep 8, 2026; 43 funds added in the latest 13F quarter.
KALBERMATTEN ADAM R
President-Chief Commercial Off
BUY
2026-06-15 SECtraded 2026-06-11
7,500
$29.5K
-20.8%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 2.4% of the 312,500 shares held after it.
  • 4 other insiders bought within 30 days.
  • 43 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President-Chief Commercial Off KALBERMATTEN ADAM R bought about $29.5K of KRMD on Jun 11, 2026; 4 other insiders bought within 30 days and 43 funds added in the latest 13F quarter.
KALBERMATTEN ADAM R
President-Chief Commercial Off
BUY
2026-06-15 SECtraded 2026-06-11
5,000
$19.8K
-20.8%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 1.6% of the 305,000 shares held after it.
  • 4 other insiders bought within 30 days.
  • 43 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President-Chief Commercial Off KALBERMATTEN ADAM R bought about $19.8K of KRMD on Jun 11, 2026; 4 other insiders bought within 30 days and 43 funds added in the latest 13F quarter.
Schiller Eric
Chief Technology Officer
BUY
2026-05-20 SECtraded 2026-05-18
5,000
$19.6K
-24.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 100.0% of the 5,000 shares held after it.
  • 4 other insiders bought within 30 days.
  • 43 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Technology Officer Schiller Eric bought about $19.6K of KRMD on May 18, 2026; 4 other insiders bought within 30 days and 43 funds added in the latest 13F quarter.
Tharby Linda M
Chief Executive Officer
BUY
2026-05-20 SECtraded 2026-05-15
1,191
$4.7K
-24.6%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Aug 18, 2023.
  • +19.6% median (+10.2% mean) 90-day return after 3 previous buys.
  • The trade is 0.2% of the 620,622 shares held after it.
  • 4 other insiders bought within 30 days.
  • 43 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Tharby Linda M bought about $4.7K of KRMD on May 15, 2026; 4 other insiders bought within 30 days and 43 funds added in the latest 13F quarter.
21 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 16 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net +$1.6M over 180 days
+$101.1K over 90 days
more than 94% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
43 funds bought in last quarter
below 62% of Medical Devices
Revenue
+22.2% year over year
more than 75% of Medical Devices
Margin
-6.4% net margin
more than 62% of Medical Devices
Buybacks
no share repurchases reported
Short interest
2.6% of the float short (float per yahoo 2026-10-27) · 4.0 days to cover · settled 2026-10-15
below 64% of Medical Devices
The situation: each line is one rule over one dataset
5 insiders bought a net $1.6M while the stock fell 23% over six months, but 1 Form 144 notice ($108.6K) are queued to sell.
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch KRMD

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-26.6%12M
-31%-3%+25%+53%2025-102025-122026-022026-042026-062026-082026-10 2026-05-15 · Tharby Linda M bought $1.4M2026-09-08 · KALBERMATTEN ADAM R bought $101.1K2026-06-11 · KALBERMATTEN ADAM R bought $29.5K2026-06-11 · KALBERMATTEN ADAM R bought $19.8K2026-05-18 · Schiller Eric bought $19.6K2026-05-14 · Adams Thomas Edward bought $19.5K2026-05-14 · Pazdan Christopher bought $19.4K2026-05-15 · Tharby Linda M bought $4.7K2026-05-14 · Adams Thomas Edward bought $1.8K2026-08-03 · KALBERMATTEN ADAM R filed to sell $108.6K
Insider buyForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns KRMD: institutional holders (13F)

13F holdings, latest reported quarter
First Light Asset Management, LLC
3,387,902 sh
$14.2M
Topline Capital Management, LLC
3,373,842 sh
$14.2M
BlackRock, Inc.
2,628,352 sh
$11.0M
VANGUARD CAPITAL MANAGEMENT LLC
1,818,121 sh
$7.6M
GEODE CAPITAL MANAGEMENT, LLC
1,128,096 sh
$4.7M

Congress trades in KRMD

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

KRMD planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
KALBERMATTEN ADAM R
Filed 2026-08-03
$108.6K

KRMD mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Ultra-Small Company Fund
$217.6K position · as of 2026-06-30
0.2%
ACUITAS US MICROCAP FUND
$235.8K position · as of 2026-06-30
0.2%
SIMT Tax-Managed Small/Mid Cap Fund
$544.8K position · as of 2026-06-30
0.1%
Fidelity Enhanced U.S. All-Cap Equity ETF
$13.1K position · as of 2026-06-30
0.1%
U.S. Small Cap Equity Fund
$103.6K position · as of 2026-06-30
0.0%
iShares Micro-Cap ETF
$636.9K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Linda Tharby
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.7M
$3.2M
$1.8M
+63%
n/a
2024
$1.3M
$1.9M
$598.9K
+8%
n/a
2023
$713.4K
-$1.2M
$547.3K
-31%
n/a
2022
$962.6K
$1.4M
$841.7K
+19%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
5 insiders reported buying shares.
The record shows a net $1.6M bought by insiders over 180 days, 43 funds added last quarter, $108.6K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

KRMD financials

Revenue growth
+22.2%
XBRL, annual
Net margin
-6.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$45.1M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-4.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$776.7K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
-10.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-6.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on capital employed
-8.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no debt line filed
FCF yield
+0.5%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$41.1M$33.6M$28.5M$27.9M
Gross profit$25.6M$21.3M$16.7M$15.4M
Operating income-$3.0M-$6.4M-$10.3M-$10.8M
Net income-$2.6M-$6.1M-$13.7M-$8.7M
EPS (diluted)-0.06-0.13-0.30-0.19
Operating cash flow$462.4K-$319.7K-$4.9M-$5.4M
Cash$8.9M$9.6M$11.5M$17.4M
SEC XBRL, fiscal years, as known on 2026-10-28

KRMD Stock Sonar score 5/7 axes

Find similar shapesCompare

KRMD ranks highest on insider conviction (94th percentile) and growth (75th), and lowest on institutional and government (38th), among Medical Devices peers.

ProfitGrowthInsidersInstitutionsRisk
Profitability
58
Inputs
  • Return on equity-10.5% · 57 pct, sector of 183
  • Return on assets-6.8% · 61 pct, sector of 214
  • Return on invested capitaltax provision or pre-tax income not filed for the four quarters
  • Return on capital employed-8.2% · 58 pct, sector of 188
Growth
75
Inputs
  • Revenue growth, YoY+22.2% · 75 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
94
Inputs
  • Net Form 4 buying (codes P and S), 180d$1.6M · 94 pct, sector of 140
  • Insider buyers, 180d5 · 94 pct, sector of 142
Institutional and government
38
Inputs
  • Funds adding, latest quarter43 · 38 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
53
Inputs
  • Short interest, % of float+2.6% · 65 pct, sector of 241
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+12.3% · 41 pct, sector of 198
2 not measured: Financial health, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

KRMD filings, in plain words

Are KORU Medical Systems insiders buying or selling KRMD?

In the 180 days to 2026-10-28, KORU Medical Systems insiders were net buyers, a net $1.6M across purchases and sales reported on Form 4, by 5 buyers.

Are there planned insider sales of KRMD?

Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $108.6K of stock; the latest, by KALBERMATTEN ADAM R, was filed 2026-08-03.

Read the full summary

In the 180 days to 2026-10-28, KORU Medical Systems insiders were net buyers of KRMD, a net $1.6M across purchases and sales reported on Form 4 by 5 buyers. 5 insiders reported purchases in that window. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $108.6K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies